Who owns RIGL?
Institutional ownership of Rigel Pharmaceuticals Inc. from Form 13F, Q2 2026
155 institutional managers reported holding Rigel Pharmaceuticals Inc. (RIGL) in Form 13F filings for Q2 2026, with 16,380,694 shares worth $640M. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 477,560 shares (+3.0%). 33 opened new positions and 26 sold out.
- Funds holding
- 155
- Value held
- $640M
- New / sold out
- 33 / 26
- Net shares, same filers
- +3.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of RIGL
Share of 13F holdings is each fund's shares as a share of the 16,380,694 RIGL shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Soleus Capital Management, L.P. Added+$71.7M
- Armistice Capital, LLC Added+$15.3M
- American Century Companies Inc Added+$7.7M
- Nomura Asset Management International Inc. New+$7.6M
- BlackRock, Inc. Added+$6.7M
- Bridgeway Capital Management, LLC New+$4.9M
- LSV Asset Management Added+$4.7M
- CenterBook Partners LP New+$4.3M
- D. E. Shaw & Co., Inc. Added+$3.8M
- Morgan Stanley Added+$3.4M
Biggest sellers in Q2 2026
- Qube Research & Technologies Ltd Sold out-$9.3M
- Marshall Wace, LLP Trimmed-$9.0M
- Nuveen, LLC Trimmed-$8.4M
- Goldman Sachs Group Inc Trimmed-$8.3M
- Two Sigma Investments, LP Trimmed-$7.8M
- Renaissance Technologies LLC Trimmed-$7.5M
- Trexquant Investment LP Trimmed-$7.2M
- Millennium Management LLC Trimmed-$6.7M
- Dimensional Fund Advisors LP Trimmed-$5.9M
- Arrowstreet Capital, Limited Partnership Sold out-$4.5M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $158M and sold $123M; 52 added and 53 trimmed.
Schedule 13D and 13G filings on RIGL
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-16AMERICAN CENTURY INVESTMENT MANAGEMENT INC SCHEDULE 13G filed by Rigel Pharmaceuticals Inc.Schedule 13G
- 2026-11-13MORGAN STANLEY SCHEDULE 13G filed by Rigel Pharmaceuticals Inc.Schedule 13G
- 2026-11-10STATE STREET CORP SCHEDULE 13G filed by Rigel Pharmaceuticals Inc.Schedule 13G
- 2026-02-09STATE STREET CORP SCHEDULE 13G filed by Rigel Pharmaceuticals Inc.Schedule 13G
- 2025-02-05BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
Questions about RIGL ownership
- Who owns RIGL stock?
- 155 institutional investment managers reported RIGL positions in their Form 13F filings for Q2 2026, holding 16,380,694 shares worth $640M in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling RIGL?
- In Q2 2026, 33 managers opened new RIGL positions, 52 added, 53 trimmed and 26 sold out. Managers that filed in both quarters added a net 477,560 shares.
- How current is this RIGL institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to RIGL by CUSIP. Options are left out. RIGL news and filings · RIGL insider trades · Top funds